MedTrace Logo

Effects of Extracorporeal Shockwave Therapy Versus Dry Needling on Jumpers Knee

NCT07756918 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2026-08-11

No results posted yet for this study

Summary

The study is randomized and single-blinded. Ethical approval is taken from ethical committee of Riphah International University, Lahore. Participants who meet the inclusion criteria will be enrolled and allocated in group A \& B through sealed envelope method by Non-probability Convenient random sampling technique. Subjects in Group A will receive Shock wave therapy. Group B will receive Dry needing.

Conditions

  • Pain
  • Quality of Life
  • Jumper's Knee

Interventions

OTHER

Extracorporeal Shockwave therapy

The participants in this group will receive Extracorporeal shockwave therapy with baseline treatment. The Frequency of sessions will be 3-5 sessions. The Intensity of the exercise related to energy levels as Low to medium energy flux density (EFD) ranges from 0.08 to 0.28 mJ/mm²

OTHER

Dry Needling

Frequency Will be 3 sessions per week. Repeated sessions over several weeks are often necessary for optimal tendon remodeling and pain relief. Intensity will be according to the depth and response-based application, Needles are inserted into myofascial trigger points (MTrPs) or directly into tendon tissue (peritendinous or intra-tendinous)

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Waqas Qadir, DPT · Study Principal Investigator

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-15
Primary Completion
2026-08-15
Completion
2026-08-30

Countries

  • Pakistan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07756918 on ClinicalTrials.gov